메뉴 건너뛰기




Volumn 25, Issue 9, 2015, Pages 1842-1848

Erratum: Corrigendum to "development of methyl isoxazoleazepines as inhibitors of BET" [Bioorganic and Medicinal Chemistry Letters (2015) 25 9 (1842-1848) 10.1016/j.bmcl.2015.03.045];Development of methyl isoxazoleazepines as inhibitors of BET

Author keywords

BET inhibitors; Bromodomains; Isoxazoles; MYC; Unbound clearance

Indexed keywords

AZEPINE DERIVATIVE; BRD2 PROTEIN, HUMAN; BRD3 PROTEIN, HUMAN; BRD4 PROTEIN, HUMAN; BRDT PROTEIN, HUMAN; METHYL ISOXAZOLEAZEPINE; NUCLEAR PROTEIN; OXAZOLE DERIVATIVE; PROTEIN SERINE THREONINE KINASE; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

EID: 84937762548     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2015.06.064     Document Type: Erratum
Times cited : (22)

References (64)
  • 47
    • 84973233240 scopus 로고    scopus 로고
    • http://www.constellationpharma.com/2014/08/constellation-expands-clinical-studies-of-cpi-0610/.
  • 53
    • 84973261290 scopus 로고    scopus 로고
    • http://www.drugtargetreview.com/941/news/industry-news/oncoethix-presents-phase-interim-results-novel-anticancer-compound-otx015-aacr-2014/#.U3TiW-ldVq0.
  • 55
    • 84937767529 scopus 로고    scopus 로고
    • PDB code 2YEK
    • PDB code 2YEK.
  • 56
    • 84937767530 scopus 로고    scopus 로고
    • PDB code 4LRG
    • PDB code 4LRG.
  • 61
    • 84937760948 scopus 로고    scopus 로고
    • only one orientation is shown for clarity
    • 2 side chain; only one orientation is shown for clarity.
    • 2 Side Chain


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.